Cost-effectiveness analysis of universal childhood vaccination against varicella in Brazil


Autoria(s): VALENTIM, J.; SARTORI, A. M. C.; SOAREZ, P. C. de; AMAKU, M.; AZEVEDO, R. S.; NOVAES, H. M. D.
Contribuinte(s)

UNIVERSIDADE DE SÃO PAULO

Data(s)

19/10/2012

19/10/2012

2008

Resumo

This study conducts a cost-effectiveness analysis of a childhood universal varicella vaccination program in Brazil. An age and time-dependent dynamic model was developed to estimate the incidence of varicella for 30 years. Assuming a single-dose schedule; vaccine efficacy of 85% and coverage of 80%, the program could prevent 74,422,058 cases and 2905 deaths. It would cost R$ 3,178,396,110 and save R$ 660,076,410 to the society and R$ 365,602,305 to the healthcare system. The program is cost-effective (R$ 14,749 and R$ 16,582 per life-year saved under the societal and the healthcare system`s perspective, respectively). The program`s cost-effectiveness is highly sensitive to the vaccine price and number of doses. (C) 2008 Elsevier Ltd. All rights reserved.

Identificador

VACCINE, v.26, n.49, Special Issue, p.6281-6291, 2008

0264-410X

http://producao.usp.br/handle/BDPI/25240

10.1016/j.vaccine.2008.07.021

http://dx.doi.org/10.1016/j.vaccine.2008.07.021

Idioma(s)

eng

Publicador

ELSEVIER SCI LTD

Relação

Vaccine

Direitos

restrictedAccess

Copyright ELSEVIER SCI LTD

Palavras-Chave #Varicella vaccine #Cost-effectiveness #Brazil #HERPES-ZOSTER EPIDEMIOLOGY #UNITED-STATES #HEALTHY-CHILDREN #BENEFIT-ANALYSIS #ECONOMIC EVALUATIONS #NEW-ZEALAND #PROGRAM #IMMUNIZATION #GERMANY #IMPACT #Immunology #Medicine, Research & Experimental
Tipo

article

original article

publishedVersion